UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

5PSQ-107 Safety assessment of erenumab and galcanezumab in clinical practice

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A148-A148

2023

Volltextzugriff (PDF)

5PSQ-066 Adequacy to protocol of use of tocilizumab for management of covd-19 disease

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A135-A135

2023

Volltextzugriff (PDF)

5PSQ-022 Analysis of infections associated with central venous catheters used for administration of parenteral nutrition in a third level hospital

European journal of hospital pharmacy. Science and practice, 2020-03, Vol.27 (Suppl 1), p.A159-A160

2020

Volltextzugriff (PDF)

5PSQ-094 Toxicity in patients treated with venetoclax. a safety study in real-world practice

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A143-A143

2023

Volltextzugriff (PDF)

4CPS-180 Vancomycin: concordance of dosage adjustment according to minimum plasma concentration and area under the curve/minimum inhibitory concentration

European journal of hospital pharmacy. Science and practice, 2023-03, Vol.30 (Suppl 1), p.A81-A82

2023

Volltextzugriff (PDF)

Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics

Endocrine, metabolic & immune disorders drug targets, 2018-01, Vol.18 (4), p.379

2018

Volltextzugriff (PDF)

Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis

Journal of clinical medicine, 2021-11, Vol.10 (22), p.5268

2021

Volltextzugriff (PDF)

Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

Nutrition, metabolism, and cardiovascular diseases, 2024-01, Vol.34 (1), p.90-97

2024

Volltextzugriff (PDF)

New technologies for the diagnosis, treatment, and monitoring of cardiovascular diseases

Revista española de cardiología (English ed.), 2024-01, Vol.77 (1), p.88-96

2024

Volltextzugriff (PDF)

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes

Journal of clinical medicine, 2022-05, Vol.11 (11), p.3008

2022

Volltextzugriff (PDF)

18F-FDG PET/CT in the diagnosis of prosthetic valve endocarditis

Revista portuguesa de cardiologia, 2018-08, Vol.37 (8), p.717.e1-717.e5

2018

Volltextzugriff (PDF)

Nuevas tecnologías para el diagnóstico, tratamiento y seguimiento de las enfermedades cardiovasculares

Revista española de cardiologia, 2024-01, Vol.77 (1), p.88-96

2024

Volltextzugriff (PDF)

Stable Angina in Spain and its Impact on Quality of Life. The AVANCE Registry

Revista española de cardiología (English ed.), 2012-08, Vol.65 (8), p.734-741

2012

Volltextzugriff (PDF)

Twenty-four-hour ambulatory heart rate and organ damage in primary hypertension

Blood pressure, 2010, Vol.19 (2), p.104-109

2010

Volltextzugriff (PDF)

The CHADS2 Score to Predict Stroke Risk in the Absence of Atrial Fibrillation in Hypertensive Patients Aged 65 Years or Older

Revista española de cardiología (English ed.), 2015-06, Vol.68 (6), p.485-491

2015

Volltextzugriff (PDF)

How beta-blockers are used in Spain? Analysis of limitations in their use in internal medicine and cardiology: CARACTER-BETA study

Revista española de cardiologia, 2011-10, Vol.64 (10), p.883-890

2011

Volltextzugriff (PDF)

Aldosterone Receptor Antagonist Use After Myocardial Infarction. Data From the REICIAM Registry

Revista española de cardiologia, 2011-11, Vol.64 (11), p.981-987

2011

Volltextzugriff (PDF)

18F-FDG PET/CT in the diagnosis of prosthetic valve endocarditis

Revista portuguesa de cardiologia (English ed.), 2018-08, Vol.37 (8), p.717.e1-717.e5

2018

Volltextzugriff (PDF)

Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el paciente hipertenso ≥ 65 años. El registro FAPRES

Revista española de cardiologia, 2010-08, Vol.63 (8), p.943-950

2010

Volltextzugriff (PDF)

USE OF ANTITHROMBOTIC DRUGS IN THE PATIENT HYPERTENSIVE OLDER THAN 65 YEARS WITH ATRIAL FIBRILLATION. THE FAPRES STUDY: PP.1.36

Journal of hypertension, 2010-06, Vol.28, p.e56-e57

2010

Volltextzugriff (PDF)

Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el paciente hipertenso ≥ 65 años. El registro FAPRES

Revista española de cardiologia, 2010-08, Vol.63 (8), p.943-950

2010

Volltextzugriff (PDF)

Comments on the ESC Guidelines on Diabetes, Prediabetes, and cardiovascular diseases developed in collaboration with the European Society for the Study of Diabetes

Revista española de cardiología (English ed.), 2014-02, Vol.67 (2), p.87-93

2014

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(12)
Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Male
(9)
Female
(8)
Cardiovascular System & Cardiology
(7)
Aged
(6)
Cardiac & Cardiovascular Systems
(6)
Middle Aged
(6)
Spain - Epidemiology
(5)
Conflicts Of Interest
(4)
Risk Factors
(4)
Cardiovascular Diseases
(3)
Clinical Trials
(3)
Cross-Sectional Studies
(3)
Diabetes Mellitus
(3)
Hypertension
(3)
Hypertension - Complications
(3)
Prevalence
(3)
Section 5: Patient Safety And Quality Assurance
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(24)
Ingenta
(17)
Elsevier ScienceDirect Journals Complete
(13)
MEDLINE
(12)
IngentaConnect Journals
(7)
Ovid Journals
(7)
BMJ Journals
(5)
Taylor & Francis Journals Complete
(1)
Taylor & Francis Journals
(1)
Taylor & Francis
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

5PSQ-107 Safety assessment of erenumab and galcanezumab in clinical practice

5PSQ-066 Adequacy to protocol of use of tocilizumab for management of covd-19 disease

5PSQ-022 Analysis of infections associated with central venous catheters used for administration of parenteral nutrition in a third level hospital

5PSQ-094 Toxicity in patients treated with venetoclax. a safety study in real-world practice

4CPS-180 Vancomycin: concordance of dosage adjustment according to minimum plasma concentration and area under the curve/minimum inhibitory concentration

Metabolic Syndrome and Cardiovascular Risk in People Treated with Long-Acting Injectable Antipsychotics

Direct Oral Anticoagulants versus Warfarin in Octogenarians with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis

Patients who suffer a first atherosclerotic cardiovascular event while taking statins are often far off of lipid targets

New technologies for the diagnosis, treatment, and monitoring of cardiovascular diseases

Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes

18F-FDG PET/CT in the diagnosis of prosthetic valve endocarditis

Information and consensus document for the detection and management of chronic kidney disease

Nuevas tecnologías para el diagnóstico, tratamiento y seguimiento de las enfermedades cardiovasculares

Stable Angina in Spain and its Impact on Quality of Life. The AVANCE Registry

Twenty-four-hour ambulatory heart rate and organ damage in primary hypertension

Documento de información y consenso para la detección y manejo de la enfermedad renal crónica

The CHADS2 Score to Predict Stroke Risk in the Absence of Atrial Fibrillation in Hypertensive Patients Aged 65 Years or Older

How beta-blockers are used in Spain? Analysis of limitations in their use in internal medicine and cardiology: CARACTER-BETA study

Aldosterone Receptor Antagonist Use After Myocardial Infarction. Data From the REICIAM Registry

18F-FDG PET/CT in the diagnosis of prosthetic valve endocarditis

Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el paciente hipertenso ≥ 65 años. El registro FAPRES

Comments on the 2019 ESC/EAS guidelines for the management of dyslipidemias

USE OF ANTITHROMBOTIC DRUGS IN THE PATIENT HYPERTENSIVE OLDER THAN 65 YEARS WITH ATRIAL FIBRILLATION. THE FAPRES STUDY: PP.1.36

Prevalencia de fibrilación auricular y uso de fármacos antitrombóticos en el paciente hipertenso ≥ 65 años. El registro FAPRES

Comments on the ESC Guidelines on Diabetes, Prediabetes, and cardiovascular diseases developed in collaboration with the European Society for the Study of Diabetes

Suchergebnisse filtern